Literature DB >> 7959793

A PCR-based genetic linkage map of human chromosome 16.

Y Shen1, H M Kozman, A Thompson, H A Phillips, K Holman, J Nancarrow, S Lane, L Z Chen, S Apostolou, N A Doggett.   

Abstract

A high-resolution cytogenetic-based physical map and a genetic linkage map of human chromosome 16 have been developed based on 79 PCR-typable genetic markers and 2 Southern-based RFLP markers. The PCR-based markers were previously characterized polymorphic (AC)n repeats. Two approaches have led to the characterization of 47 highly informative genetic markers spread along chromosome 16, some of which are closely linked to disease loci. In addition, 22 markers (D16S401-423) previously genetically mapped were also physically mapped. Ten markers characterized by other laboratories were physically mapped and genotyped on the CEPH families. These 32 markers were incorporated into the PCR-based map. Seventy-two markers have heterozygosities > 0.50 and 51 of these markers > 0.70. By multipoint linkage analysis a framework genetic map and a comprehensive genetic map were constructed. The length of the sex-averaged framework genetic map is 152.1 cM. The average distance and the median distance between markers on this map are 3.2 and 2.7 cM, respectively, and the largest gap is 15.9 cM. These maps were anchored to the high-resolution cytogenetic map (on average 1.5 Mb per interval). Together these integrated genetic and physical maps of human chromosome 16 provide the basis for the localization and ultimately the isolation of disease genes that map to this chromosome.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7959793     DOI: 10.1006/geno.1994.1346

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  13 in total

1.  Genetic maps of microsatellite and single-nucleotide polymorphism markers: are the distances accurate?

Authors:  Suzanne M Leal
Journal:  Genet Epidemiol       Date:  2003-05       Impact factor: 2.135

2.  Genetic linkage of familial granulomatous inflammatory arthritis, skin rash, and uveitis to chromosome 16.

Authors:  G Tromp; H Kuivaniemi; S Raphael; L Ala-Kokko; A Christiano; E Considine; R Dhulipala; J Hyland; A Jokinen; S Kivirikko; R Korn; S Madhatheri; S McCarron; L Pulkkinen; H Punnett; K Shimoya; L Spotila; A Tate; C J Williams
Journal:  Am J Hum Genet       Date:  1996-11       Impact factor: 11.025

3.  Report of a critical recombination further narrowing the TSC1 region.

Authors:  K S Au; J Murrell; A Buckler; S H Blanton; H Northrup
Journal:  J Med Genet       Date:  1996-07       Impact factor: 6.318

4.  Recombination and maternal age-dependent nondisjunction: molecular studies of trisomy 16.

Authors:  T Hassold; M Merrill; K Adkins; S Freeman; S Sherman
Journal:  Am J Hum Genet       Date:  1995-10       Impact factor: 11.025

5.  Genetic heterogeneity in familial acute myelogenous leukemia: evidence for a second locus at chromosome 16q21-23.2.

Authors:  M Horwitz; K F Benson; F Q Li; J Wolff; M F Leppert; L Hobson; M Mangelsdorf; S Yu; D Hewett; R I Richards; W H Raskind
Journal:  Am J Hum Genet       Date:  1997-10       Impact factor: 11.025

6.  Loss of tuberin in both subependymal giant cell astrocytomas and angiomyolipomas supports a two-hit model for the pathogenesis of tuberous sclerosis tumors.

Authors:  E P Henske; L L Wessner; J Golden; B W Scheithauer; A O Vortmeyer; Z Zhuang; A J Klein-Szanto; D J Kwiatkowski; R S Yeung
Journal:  Am J Pathol       Date:  1997-12       Impact factor: 4.307

7.  Tuberous sclerosis-associated renal cell carcinoma. Clinical, pathological, and genetic features.

Authors:  J Bjornsson; M P Short; D J Kwiatkowski; E P Henske
Journal:  Am J Pathol       Date:  1996-10       Impact factor: 4.307

8.  Allelic loss is frequent in tuberous sclerosis kidney lesions but rare in brain lesions.

Authors:  E P Henske; B W Scheithauer; M P Short; R Wollmann; J Nahmias; N Hornigold; M van Slegtenhorst; C T Welsh; D J Kwiatkowski
Journal:  Am J Hum Genet       Date:  1996-08       Impact factor: 11.025

9.  Loss of the polycystic kidney disease (PKD1) region of chromosome 16p13 in renal cyst cells supports a loss-of-function model for cyst pathogenesis.

Authors:  J L Brasier; E P Henske
Journal:  J Clin Invest       Date:  1997-01-15       Impact factor: 14.808

10.  Batten disease gene, CLN3: linkage disequilibrium mapping in the Finnish population, and analysis of European haplotypes.

Authors:  H M Mitchison; A M O'Rawe; P E Taschner; L A Sandkuijl; P Santavuori; N de Vos; M H Breuning; S E Mole; R M Gardiner; I E Järvelä
Journal:  Am J Hum Genet       Date:  1995-03       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.